» Articles » PMID: 35086214

Assessment of Retinal Manifestations of Parkinson's Disease Using Spectral Domain Optical Coherence Tomography: A Study in Indian Eyes

Overview
Specialty Ophthalmology
Date 2022 Jan 28
PMID 35086214
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To assess the retinal manifestations of Parkinson's disease using optical coherence tomography.

Methods: A prospective case-control study comparing 30 eyes from 15 patients with Parkinson's disease and 22 eyes from 11 healthy age-matched controls. Total macular subfield thickness and the thickness of the ganglion cell layer, nerve fiber layer, and peripapillary retinal nerve fiber layer were measured with spectral-domain optical coherence tomography (SD-OCT).

Results: The mean age of PD patients was 68.4 years ± 10.64 (range: 46-82) and in the control group was 66.36 ± 5.22 (range: 64-68). The average disease duration in patients with PD was 6.7 ± 2.8 years (range: 2-10 years). The mean best-corrected visual acuity in PD was 20/26 and 20/20 in controls, with P = 0.0059, which was significant. Significant difference was also found in the contrast sensitivity between both groups. Structural differences in the central macular thickness (P = 0.0001), subfield thicknesses in the superior (P = 0.003), inferior (P = 0.001), nasal (P = 0.004), and temporal subfields (P = 0.017) was seen. Severe thinning of the ganglion cell layer was seen in PD patients (P = 0.000) as well as of the nerve fiber layer (P = 0.004). Peripapillary retinal nerve fiber thickness measured showed significant thinning in superotemporal (P = 0.000), superonasal (P = 0.04), inferonasal (P = 0.000), inferotemporal (P = 0.000), nasal (P = 0.000), and temporal quadrants (P = 0.000).

Conclusion: Visual dysfunction was observed in patients with PD along with structural alterations on OCT, which included macular volumes, ganglion cell layer, and peripapillary retinal nerve fiber layer.

Citing Articles

The Role of Alpha-Synuclein Deposits in Parkinson's Disease: A Focus on the Human Retina.

Di Pippo M, Fragiotta S, Di Staso F, Scuderi L, Abdolrahimzadeh S Int J Mol Sci. 2023; 24(5).

PMID: 36901822 PMC: 10002434. DOI: 10.3390/ijms24054391.

References
1.
Kirbas S, Turkyilmaz K, Tufekci A, Durmus M . Retinal nerve fiber layer thickness in Parkinson disease. J Neuroophthalmol. 2012; 33(1):62-5. DOI: 10.1097/WNO.0b013e3182701745. View

2.
Jimenez B, Ascaso F, Cristobal J, Del Val J . Development of a prediction formula of Parkinson disease severity by optical coherence tomography. Mov Disord. 2014; 29(1):68-74. DOI: 10.1002/mds.25747. View

3.
Moschos M, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M . Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol. 2010; 21(1):24-9. DOI: 10.5301/ejo.2010.1318. View

4.
Shrier E, Adam C, Spund B, Glazman S, Bodis-Wollner I . Interocular asymmetry of foveal thickness in Parkinson disease. J Ophthalmol. 2012; 2012:728457. PMC: 3415246. DOI: 10.1155/2012/728457. View

5.
Nguyen-Legros J . Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease. Surg Radiol Anat. 1988; 10(2):137-44. DOI: 10.1007/BF02307822. View